Announcement on Serious Abnormal Fluctuations in Stock Trading
Filed with SSE · · 5 pages · Chinese
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. on 6ix
Earlier from Sunshine Guojian Pharmaceutical (Shanghai)
- Report for Q1 2026
- Announcement on Expanding Business Scope and Amending "Articles of Association"
- Announcement on Changing Audit Institution for 2026
- Announcement on Resolutions of the 14th Meeting of the 5th Board of Directors
- Announcement on Equity Change of Shareholders Reaching 1% Scale and Results of Shareholding Reduction
Later from Sunshine Guojian Pharmaceutical (Shanghai)
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on the Listing and Trading of the Shares Vested during the First Vesting Period of the Initial Grant under the 2024 Restricted Stock Incentive Plan
- Sunshine Guojian Releases 2026 Interim Report:
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Sunshine Guojian Pharmaceutical (Shanghai) into a list and get an email when it puts out news.
Follow Sunshine Guojian Pharmaceutical (Shanghai)